Skip to content
Sheel Biotech logo

Sheel Biotech

SHEEL NSE
₹56.15 down 2.55 (4.34%)
Market Cap
₹114 Cr

Sheel Biotech (SHEEL) share price was ₹58.70 at the 27 Oct 2026 close; market capitalisation ₹119 Cr; sector Commercial Services. The share price fell 27.1% over the year to 27 Oct 2026 (adjusted for splits and bonuses). In the Sep 2025 quarter, revenue was ₹22 Cr, against ₹11 Cr a year earlier and net profit was under ₹1 Cr, against −₹4 Cr a year earlier (compared with Sep 2024). Promoters held 72.31% of Sheel Biotech in Sep 2026, up 0.01 percentage points from Mar 2026. Its Tapetide Score is 54/100 (Average) as of 28 Oct 2026.

Close 27 Oct 2026 ₹58.70 −20.30 −25.70% 1Y

Key Fundamentals

SMECommercial ServicesServices
Market Cap
₹114 Cr
EBITDA
₹17.00 Cr
Return on Equity
9.26%
Debt to Equity
0.07
Book Value
₹62.40
EPS (TTM)
—
52W High
₹82.00
52W Low
₹37.80

Price-based figures as of 29 Oct 2026, 09:08 IST · TTM

Peer Comparison

Services › Commercial Services › Diversified Services › Diversified Commercial Services

₹405.7028.7517,533 Cr10.010.65%47.80%58.83%1,521 Cr611 Cr
₹640.85105.238,900 Cr26.150.00%64.94%11.08%2,850 Cr82 Cr
₹31.8217.117,421 Cr2.080.00%11.14%6.24%1,121 Cr488 Cr
₹1,007.3017.047,097 Cr2.250.71%13.77%15.50%1,055 Cr417 Cr
₹631.0015.935,686 Cr12.134.76%73.83%23.30%689 Cr357 Cr
₹120.30—5,300 Cr3.510.00%6.19%9.00%821 Cr75 Cr
Sheel Biotech (this company)
₹56.15—114 Cr0.900.00%9.26%12.37%——
Median 7 companies₹405.7017.117,097 Cr3.510.00%13.77%12.37%1,088 Cr387 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

54 Average
Overall score

Data confidence 84/100

Category scores

Quality Average 52
Returns, margins, earnings quality 22% weight
Valuation Weak 39
Cheap vs sector & own history 24% weight
Growth Average 51
Sales & profit trajectory 9% weight
Financial Health Strong 79
Solvency, leverage, coverage 9% weight
Momentum Strong 80
Trend strength, vol-adjusted 12% weight
Ownership Average 52
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 1.00 times its book value
  • Company has delivered good profit growth of 20.2% CAGR over last 5 years

Weaknesses

3
  • The company has delivered a poor sales growth of 11.8% over past five years.
  • Company has a low return on equity of 13.0% over last 3 years.
  • Company has high debtors of 205 days.

Technical Indicators

Oscillators

Bearish

Bearish
2
Neutral
6
Bullish
1

Overall

Bearish

Bearish
11
Neutral
6
Bullish
2

Moving Averages

Bearish

Bearish
9
Neutral
0
Bullish
1

Growth Rate

Revenue Growth
8.21% higher than 3Y

change over 1 year

Net Income Growth
9.26% lower than 3Y

change over 1 year

Cash Flow Change
-306%

change over 1 year

EBITDA Margin Change
1.32%

change over 1 year Operating margin 8% · Sep 2025

Quarterly Results

Particulars Sep 2024Sep 2025
Sales
11
22
Expenses
14
20
Operating Profit
-2
2
OPM %
-22%
8%
Other Income
0
0
Interest
1
1
Depreciation
0
1
PBT
-4
0
Tax %
3%
24%
Net Profit
-4
0
EPS (₹)
-2.53
0.13
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
63
84
89
103
102
110
Expenses
56
78
80
89
87
94
Operating Profit
7
6
9
14
15
16
OPM %
10%
8%
10%
14%
15%
15%
Other Income
0
0
0
0
1
1
Interest
1
1
2
1
2
2
Depreciation
1
1
1
1
1
1
PBT
5
5
6
12
13
14
Tax %
0%
2%
20%
15%
16%
16%
Net Profit
5
5
5
10
11
12
EPS (₹)
3.31
3.11
3.5
7.22
7.2
5.78
Div. Payout %
0%
28%
25%
12%
14%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
4
4
4
15
20
Reserves
53
56
59
69
69
107
Borrowings
21
24
19
24
17
9
Other Liabilities
4
10
11
10
10
10
Total Liabilities
82
93
94
106
111
146
Fixed Assets
8
8
8
7
7
9
CWIP
0
0
0
0
0
3
Investments
0
1
1
1
1
1
Other Assets
75
84
85
98
103
132
Total Assets
82
93
94
106
111
146
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
2
9
-1
9
-18
Investing
—
-2
-2
0
-2
-7
Financing
—
0
-7
2
-6
26
Net Cash Flow
—
0
0
0
0
2
Free Cash Flow
—
1
8
-1
7
-24
CFO/EBITDA
—
37
105
3
71
-94
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
352
280
230
204
198
205
Inventory Days
55
120
177
263
272
212
Days Payable
30
85
75
37
29
22
Cash Conversion Cycle
377
315
332
430
441
395
Working Capital Days
348
274
255
256
275
361
ROCE %
—
7%
10%
15%
14%
13%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sheel Biotech insights

53 extracted metrics + investor summaries across FY21–FY26.

Shareholding Pattern

Others5.80%Promot.72.31%DIIs9.66%Public12.24%As ofSep 2026

Documents

Frequently Asked Questions about Sheel Biotech

What does Sheel Biotech Ltd do?
Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]
Where is Sheel Biotech Ltd (SHEEL) listed?
Sheel Biotech Ltd trades as SHEEL on the NSE.
Which sector does Sheel Biotech Ltd belong to?
Sheel Biotech Ltd is classified under the Commercial Services sector, in the Diversified Services industry.
What is the market capitalisation of Sheel Biotech Ltd?
Sheel Biotech Ltd has a market capitalisation of ₹114.28 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Sheel Biotech Ltd?
Over the last 52 weeks Sheel Biotech Ltd has traded between ₹37.8 and ₹82 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Sheel Biotech Ltd?
Sheel Biotech Ltd reported a return on equity of 9.26%. Its debt-to-equity ratio is 0.07.

Company Information

Incorporated in November 1994, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects.[1]

Listed 2025-10-08
Face Value ₹ 10
Shares Outstanding 2,03,52,550

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SHEEL.md for Sheel Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More